Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain

Non-specific chronic low back pain (cLBP) represents a common musculoskeletal condition with no identifiable cause. It cannot be diagnosed with conventional neuroimaging techniques such as computerized tomography (CT). The diagnostic uncertainty that characterizes non-specific cLBP can lead to stigm...

Full description

Bibliographic Details
Published in:Frontiers in Pain Research
Main Authors: Aroke, Edwin N., Hobson, Joanna M., Ptacek, Travis, Jackson, Pamela, Goodin, Burel R.
Other Authors: National Institutes of Health
Format: Article in Journal/Newspaper
Language:unknown
Published: Frontiers Media SA 2022
Subjects:
DML
Online Access:http://dx.doi.org/10.3389/fpain.2022.1021963
https://www.frontiersin.org/articles/10.3389/fpain.2022.1021963/full
id crfrontiers:10.3389/fpain.2022.1021963
record_format openpolar
spelling crfrontiers:10.3389/fpain.2022.1021963 2024-04-21T08:01:02+00:00 Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain Aroke, Edwin N. Hobson, Joanna M. Ptacek, Travis Jackson, Pamela Goodin, Burel R. National Institutes of Health 2022 http://dx.doi.org/10.3389/fpain.2022.1021963 https://www.frontiersin.org/articles/10.3389/fpain.2022.1021963/full unknown Frontiers Media SA https://creativecommons.org/licenses/by/4.0/ Frontiers in Pain Research volume 3 ISSN 2673-561X journal-article 2022 crfrontiers https://doi.org/10.3389/fpain.2022.1021963 2024-03-26T08:33:25Z Non-specific chronic low back pain (cLBP) represents a common musculoskeletal condition with no identifiable cause. It cannot be diagnosed with conventional neuroimaging techniques such as computerized tomography (CT). The diagnostic uncertainty that characterizes non-specific cLBP can lead to stigmatizing responses from others that can become internalized Among individuals with non-specific cLBP, internalized stigma is associated with greater pain intensity and disability. Yet, no study has examined the biological mechanism linking high internalized stigma to worse outcomes in individuals with non-specific cLBP. We aimed to identify differentially methylated loci (DML), enrichment pathways, and associated network interactions among individuals with non-specific cLBP experiencing low vs. high internalized stigma. We examined DNA methylation in whole blood samples from 48 adults, ages 19–85, using reduced representation bisulfite sequencing (RRBS). After controlling for age, sex, race, and multiple testing, differentially methylated loci (DML) differed in adults with low vs. high internalized stigma by at least 10% and q < 0.01 in 3,665 CpG sites: 2,280 hypomethylated and 1,385 hypermethylated. Gene ontology (GO) analyses of the annotated genes from these sites revealed significant enrichment of 274 biological processes, 29 cellular components, and 24 molecular functions (adjusted p < 0.05). The top enriched molecular functions regulate protein binding and DNA binding of transcription factor activity. Pathway analyses indicated that many functional genomic pathways, including Hippo Signaling, Melanogenesis, and Pathways in Cancer, were enriched with differentially methylated genes. Also, there was a significant interaction between relevance pathways such as P53 , mTOR , PI3K-Akt , and Wnt signaling pathways. These pathways have previously been associated with neuroinflammation, neurodegeneration, and stress-related conditions. Thus, findings point to possible stress-induced DNAm changes as the link ... Article in Journal/Newspaper DML Frontiers (Publisher) Frontiers in Pain Research 3
institution Open Polar
collection Frontiers (Publisher)
op_collection_id crfrontiers
language unknown
description Non-specific chronic low back pain (cLBP) represents a common musculoskeletal condition with no identifiable cause. It cannot be diagnosed with conventional neuroimaging techniques such as computerized tomography (CT). The diagnostic uncertainty that characterizes non-specific cLBP can lead to stigmatizing responses from others that can become internalized Among individuals with non-specific cLBP, internalized stigma is associated with greater pain intensity and disability. Yet, no study has examined the biological mechanism linking high internalized stigma to worse outcomes in individuals with non-specific cLBP. We aimed to identify differentially methylated loci (DML), enrichment pathways, and associated network interactions among individuals with non-specific cLBP experiencing low vs. high internalized stigma. We examined DNA methylation in whole blood samples from 48 adults, ages 19–85, using reduced representation bisulfite sequencing (RRBS). After controlling for age, sex, race, and multiple testing, differentially methylated loci (DML) differed in adults with low vs. high internalized stigma by at least 10% and q < 0.01 in 3,665 CpG sites: 2,280 hypomethylated and 1,385 hypermethylated. Gene ontology (GO) analyses of the annotated genes from these sites revealed significant enrichment of 274 biological processes, 29 cellular components, and 24 molecular functions (adjusted p < 0.05). The top enriched molecular functions regulate protein binding and DNA binding of transcription factor activity. Pathway analyses indicated that many functional genomic pathways, including Hippo Signaling, Melanogenesis, and Pathways in Cancer, were enriched with differentially methylated genes. Also, there was a significant interaction between relevance pathways such as P53 , mTOR , PI3K-Akt , and Wnt signaling pathways. These pathways have previously been associated with neuroinflammation, neurodegeneration, and stress-related conditions. Thus, findings point to possible stress-induced DNAm changes as the link ...
author2 National Institutes of Health
format Article in Journal/Newspaper
author Aroke, Edwin N.
Hobson, Joanna M.
Ptacek, Travis
Jackson, Pamela
Goodin, Burel R.
spellingShingle Aroke, Edwin N.
Hobson, Joanna M.
Ptacek, Travis
Jackson, Pamela
Goodin, Burel R.
Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
author_facet Aroke, Edwin N.
Hobson, Joanna M.
Ptacek, Travis
Jackson, Pamela
Goodin, Burel R.
author_sort Aroke, Edwin N.
title Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
title_short Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
title_full Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
title_fullStr Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
title_full_unstemmed Genome-wide DNA methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
title_sort genome-wide dna methylation study identifies significant epigenomic changes associated with internalized stigma in adults with non-specific chronic low back pain
publisher Frontiers Media SA
publishDate 2022
url http://dx.doi.org/10.3389/fpain.2022.1021963
https://www.frontiersin.org/articles/10.3389/fpain.2022.1021963/full
genre DML
genre_facet DML
op_source Frontiers in Pain Research
volume 3
ISSN 2673-561X
op_rights https://creativecommons.org/licenses/by/4.0/
op_doi https://doi.org/10.3389/fpain.2022.1021963
container_title Frontiers in Pain Research
container_volume 3
_version_ 1796941395463766016